Skip to content
lifestyle.independent.mk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Adaptive Biotechnologies
Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026
October 14, 2026
Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure
September 25, 2026
Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
September 17, 2026
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
July 29, 2026
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
May 24, 2026
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
May 16, 2026
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026